Bipolar disorder pharma market share in 8 major markets for 2014 & 2024

Published by Statista Research Department, Mar 1, 2016
This statistic shows the comparison of the bipolar disorder market among 8 major pharmaceutical markets in 2014 and 2024. The sales share of Canada among these markets was 2.9 percent in 2014 and it is predicted to increase to 3.8 percent in 2024.

Share of bipolar disorder pharmaceutical sales among 8 major markets in 2014 and 2024

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2016

Region

Worldwide

Survey time period

as of March 2016

Supplementary notes

8 major markets = US, France, Germany, Italy, Spain, UK, Japan, and Canada. Totals may not sum due to rounding.
* Forecast

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Boiron "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Boiron

Overview

5

Turnover

5

Financial data

7

Workforce

6

Shares

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the UKGlobal pharmaceutical industryPharmaceutical industry in the U.S.AstraZenecaNational Health Service (NHS) UK
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.